Gameto announced that it has exclusively licensed additional intellectual property from Harvard University related to the induction of meiosis in human cells. This meiosis-induction approach will be integrated with its proprietary ovarian organoid platform to induce human oogonia to enter early meiotic stages in vitro.
[Gameto (Globe Newswire) ]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News